$DGX
QUEST DIAGNOSTICS INC

2021 Q4 Form 10-Q Financial Statement

#000102207921000144 Filed on October 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $2.744B $0.00 $0.00
YoY Change -8.59% -100.0%
Cost Of Revenue $1.679B $1.670B $1.580B
YoY Change -7.85% 5.7% 25.0%
Gross Profit $1.065B -$1.670B $1.206B
YoY Change -16.08% -238.47% 74.28%
Gross Profit Margin 38.81%
Selling, General & Admin $442.0M $427.0M $396.0M
YoY Change 1.38% 7.83% 9.39%
% of Gross Profit 41.5% 32.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $106.0M $101.0M $89.00M
YoY Change 8.16% 13.48% 8.54%
% of Gross Profit 9.95% 7.38%
Operating Expenses $468.0M $427.0M $396.0M
YoY Change 1.3% 7.83% 9.39%
Operating Profit $597.0M $652.0M $718.0M
YoY Change -26.02% -9.19% 129.39%
Interest Expense -$37.00M $38.00M $42.00M
YoY Change -5.13% -9.52% -6.67%
% of Operating Profit -6.2% 5.83% 5.85%
Other Income/Expense, Net $3.000M $2.000M $35.00M
YoY Change 50.0% -94.29% -181.4%
Pretax Income $502.0M $654.0M $753.0M
YoY Change -33.77% -13.15% 178.89%
Income Tax $114.0M $153.0M $177.0M
% Of Pretax Income 22.71% 23.39% 23.51%
Net Earnings $390.0M $505.0M $568.0M
YoY Change -32.64% -11.09% 164.19%
Net Earnings / Revenue 14.21%
Basic Earnings Per Share $4.11 $4.20
Diluted Earnings Per Share $3.120M $4.02 $4.14
COMMON SHARES
Basic Shares Outstanding 122.7M shares 123.0M shares 135.0M shares
Diluted Shares Outstanding 125.0M shares 137.0M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $872.0M $987.0M $1.605B
YoY Change -24.7% -38.5% 269.82%
Cash & Equivalents $872.0M $987.0M $1.605B
Short-Term Investments
Other Short-Term Assets $223.0M $189.0M $115.0M
YoY Change 44.81% 64.35% 0.0%
Inventory $208.0M $205.0M $205.0M
Prepaid Expenses
Receivables $1.438B $1.473B $1.421B
Other Receivables $0.00 $0.00 $2.000M
Total Short-Term Assets $2.741B $2.854B $3.348B
YoY Change -10.37% -14.76% 88.2%
LONG-TERM ASSETS
Property, Plant & Equipment $1.707B $1.634B $1.544B
YoY Change 4.92% 5.83% 14.29%
Goodwill $7.095B $7.057B $6.880B
YoY Change 3.23% 2.57% 3.97%
Intangibles $1.167B $1.152B $1.192B
YoY Change 0.0% -3.36% 4.75%
Long-Term Investments $141.0M $124.0M $480.0M
YoY Change -72.94% -74.17% 1.27%
Other Assets $163.0M $155.0M $164.0M
YoY Change -7.39% -5.49% 7.89%
Total Long-Term Assets $10.87B $10.72B $10.80B
YoY Change -0.89% -0.71% 5.42%
TOTAL ASSETS
Total Short-Term Assets $2.741B $2.854B $3.348B
Total Long-Term Assets $10.87B $10.72B $10.80B
Total Assets $13.61B $13.57B $14.14B
YoY Change -2.96% -4.04% 17.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.600B $1.610B $1.686B
YoY Change -2.02% -4.51% 59.21%
Accrued Expenses $460.0M $148.0M $148.0M
YoY Change 29.21% 0.0% 0.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $1.000M $555.0M
YoY Change 0.0% -99.82% -31.06%
Total Short-Term Liabilities $1.753B $1.759B $2.389B
YoY Change -1.3% -26.37% 18.8%
LONG-TERM LIABILITIES
Long-Term Debt $4.010B $4.006B $4.018B
YoY Change -0.07% -0.3% 26.04%
Other Long-Term Liabilities $792.0M $801.0M $782.0M
YoY Change -6.49% 2.43% 14.16%
Total Long-Term Liabilities $4.802B $801.0M $4.800B
YoY Change -1.19% -83.31% 23.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.753B $1.759B $2.389B
Total Long-Term Liabilities $4.802B $801.0M $4.800B
Total Liabilities $6.555B $2.560B $7.189B
YoY Change -1.22% -64.39% 22.18%
SHAREHOLDERS EQUITY
Retained Earnings $7.649B $7.333B $8.800B
YoY Change -17.78% -16.67% 10.11%
Common Stock $2.262B $1.938B $2.803B
YoY Change -20.44% -30.86% 3.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.453B $2.866B $5.161B
YoY Change -35.65% -44.47% 2.42%
Treasury Stock Shares 43.00M shares 39.00M shares 82.00M shares
Shareholders Equity $6.444B $6.392B $6.400B
YoY Change
Total Liabilities & Shareholders Equity $13.61B $13.57B $14.14B
YoY Change -2.96% -4.04% 17.67%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $390.0M $505.0M $568.0M
YoY Change -32.64% -11.09% 164.19%
Depreciation, Depletion And Amortization $106.0M $101.0M $89.00M
YoY Change 8.16% 13.48% 8.54%
Cash From Operating Activities $481.0M $561.0M $862.0M
YoY Change -11.09% -34.92% 188.29%
INVESTING ACTIVITIES
Capital Expenditures -$144.0M -$89.00M -$91.00M
YoY Change -11.11% -2.2% -5.21%
Acquisitions $20.00M $101.0M
YoY Change -80.2%
Other Investing Activities -$83.00M -$7.000M -$102.0M
YoY Change 1283.33% -93.14% 684.62%
Cash From Investing Activities -$227.0M -$96.00M -$193.0M
YoY Change 35.12% -50.26% 77.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -369.0M -38.00M -52.00M
YoY Change -55.0% -26.92% 79.31%
NET CHANGE
Cash From Operating Activities 481.0M 561.0M 862.0M
Cash From Investing Activities -227.0M -96.00M -193.0M
Cash From Financing Activities -369.0M -38.00M -52.00M
Net Change In Cash -115.0M 427.0M 617.0M
YoY Change -74.27% -30.79% 283.23%
FREE CASH FLOW
Cash From Operating Activities $481.0M $561.0M $862.0M
Capital Expenditures -$144.0M -$89.00M -$91.00M
Free Cash Flow $625.0M $650.0M $953.0M
YoY Change -11.1% -31.79% 141.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001022079
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12215
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Plaza Drive
dei City Area Code
CityAreaCode
(973)
dei Local Phone Number
LocalPhoneNumber
520-2700
dei Entity Registrant Name
EntityRegistrantName
Quest Diagnostics Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1387862
dei Entity Address City Or Town
EntityAddressCityOrTown
Secaucus,
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07094
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value
dei Trading Symbol
TradingSymbol
DGX
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
122674771 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2774000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2786000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8044000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6435000000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
1670000000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1580000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
4861000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
4071000000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
427000000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
396000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1263000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1103000000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25000000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000000 USD
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-65000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-8000000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
2122000000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
2068000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6199000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
5259000000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
652000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
718000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1845000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1176000000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-114000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-124000000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
366000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
252000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50000000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
654000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
753000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2097000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1126000000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
153000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
483000000 USD
us-gaap Net Income Loss
NetIncomeLoss
852000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
269000000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
26000000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
53000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
33000000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
527000000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
591000000 USD
us-gaap Profit Loss
ProfitLoss
1667000000 USD
us-gaap Profit Loss
ProfitLoss
890000000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
22000000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
23000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
62000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38000000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
568000000 USD
us-gaap Net Income Loss
NetIncomeLoss
1605000000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.11
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.02
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.25
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136000000 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
527000000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
591000000 USD
us-gaap Profit Loss
ProfitLoss
1667000000 USD
us-gaap Profit Loss
ProfitLoss
890000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7000000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1000000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
524000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
604000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1675000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
887000000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
22000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
23000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
62000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
38000000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
502000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
581000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1613000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
849000000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
987000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1158000000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1473000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1520000000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
205000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
223000000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
189000000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
157000000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2854000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3058000000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1634000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1627000000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
596000000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604000000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
7057000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
6873000000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1152000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1167000000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
124000000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
521000000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
155000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
176000000 USD
CY2021Q3 us-gaap Assets
Assets
13572000000 USD
CY2020Q4 us-gaap Assets
Assets
14026000000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1610000000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1633000000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
148000000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
141000000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1759000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1776000000 USD
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4006000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4013000000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
495000000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
499000000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
801000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
847000000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
79000000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
82000000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217000000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1936000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2841000000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7333000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9303000000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21000000 USD
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
39000000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
84000000 shares
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
2866000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5366000000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
6392000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6759000000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
40000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
50000000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6432000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6809000000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13572000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14026000000 USD
us-gaap Profit Loss
ProfitLoss
1667000000 USD
us-gaap Profit Loss
ProfitLoss
890000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
302000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
263000000 USD
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
3000000 USD
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
18000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-87000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
60000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
63000000 USD
dgx Gain Loss On Disposition Of Joint Venture
GainLossOnDispositionOfJointVenture
314000000 USD
dgx Gain Loss On Disposition Of Joint Venture
GainLossOnDispositionOfJointVenture
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
48000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
60000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
355000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
514000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
49000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
95000000 USD
dgx Termination Of Interest Rate Swap Agreements
TerminationOfInterestRateSwapAgreements
0 USD
dgx Termination Of Interest Rate Swap Agreements
TerminationOfInterestRateSwapAgreements
40000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-39000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
16000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1752000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1464000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
251000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
329000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
259000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
256000000 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
755000000 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
19000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
248000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-604000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
749000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
2000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1002000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1910000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
108000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
144000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13000000 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
34000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
232000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
222000000 USD
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
75000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-38000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
6000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2171000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-447000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-171000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
413000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1158000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1192000000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
987000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1605000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5940000000 USD
CY2021Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
78000000 USD
CY2021Q3 dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
524000000 USD
CY2021Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
3000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 USD
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
76000000 USD
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20000000 USD
CY2021Q3 dgx Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders
TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
2000000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21000000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000000 USD
CY2021Q3 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6432000000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
79000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6809000000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
82000000 USD
dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
1658000000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
9000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
233000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
63000000 USD
dgx Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders
TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
12000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60000000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
22000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1910000000 USD
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6432000000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
79000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5881000000 USD
CY2020Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
77000000 USD
CY2020Q3 dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
586000000 USD
CY2020Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
5000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 USD
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
75000000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22000000 USD
CY2020Q3 dgx Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders
TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
2000000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6446000000 USD
CY2020Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
80000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5687000000 USD
CY2019Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
76000000 USD
dgx Net Income Loss Excluding Redeemable Noncontrolling Interest
NetIncomeLossExcludingRedeemableNoncontrollingInterest
883000000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
7000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
226000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
31000000 USD
dgx Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders
TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
3000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63000000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
144000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
75000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6446000000 USD
CY2020Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
80000000 USD
us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span></div>    Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.  The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services. The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs"). The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals. The Company is the world's leading provider of diagnostic information services. The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
503000000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
568000000 USD
us-gaap Net Income Loss
NetIncomeLoss
1605000000 USD
us-gaap Net Income Loss
NetIncomeLoss
852000000 USD
CY2021Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2000000 USD
CY2020Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
2000000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
6000000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
566000000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1599000000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
849000000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134000000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136000000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.11
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.33
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.02
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.25
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
42000000 USD
CY2021Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4500000000 USD
CY2020Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4600000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
6873000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
6619000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
188000000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
247000000 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-4000000 USD
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
7000000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
7057000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
6873000000 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2030000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
878000000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1152000000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1967000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
800000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1167000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
26000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
102000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
100000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
97000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
96000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
90000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
405000000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
916000000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000000 USD
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2100000 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
366000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
CY2021Q1 dgx Stock Repurchase Program Additional Amount Authorized
StockRepurchaseProgramAdditionalAmountAuthorized
1000000000 USD
CY2021Q1 dgx Stock Repurchase Program Additional Amount Authorized
StockRepurchaseProgramAdditionalAmountAuthorized
1000000000 USD
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1300000000 USD
us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
132.27
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1700000 shares
CY2021Q3 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
55000000 shares
CY2021Q3 us-gaap Depreciation
Depreciation
76000000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
62000000 USD
us-gaap Depreciation
Depreciation
225000000 USD
us-gaap Depreciation
Depreciation
186000000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25000000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
101000000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
89000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
302000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
263000000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
38000000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
42000000 USD
us-gaap Interest Expense
InterestExpense
114000000 USD
us-gaap Interest Expense
InterestExpense
126000000 USD
CY2021Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
0 USD
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
0 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
0 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2000000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-114000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-124000000 USD
CY2021Q3 dgx Interest Paid1
InterestPaid1
33000000 USD
CY2020Q3 dgx Interest Paid1
InterestPaid1
33000000 USD
dgx Interest Paid1
InterestPaid1
111000000 USD
dgx Interest Paid1
InterestPaid1
136000000 USD
CY2021Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
187000000 USD
CY2020Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
148000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
522000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
168000000 USD
CY2021Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000000 USD
CY2020Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
55000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
55000000 USD
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
77000000 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
76000000 USD
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
77000000 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
76000000 USD
CY2021Q3 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
20000000 USD
CY2020Q3 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
126000000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
254000000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
377000000 USD
CY2021Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2020Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
9000000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
3000000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
29000000 USD
CY2021Q3 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
20000000 USD
CY2020Q3 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
117000000 USD
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
251000000 USD
dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
348000000 USD
CY2021Q3 dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
0 USD
CY2020Q3 dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
2000000 USD
dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
0 USD
dgx Mergerconsiderationpaidpayablenet
Mergerconsiderationpaidpayablenet
2000000 USD
CY2021Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
20000000 USD
CY2020Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
119000000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
251000000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
350000000 USD
CY2021Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2020Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
18000000 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
21000000 USD
CY2021Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20000000 USD
CY2020Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
101000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
251000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
329000000 USD
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46000000 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
40000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
115000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
119000000 USD
CY2020Q2 dgx Cares Act Related Expensesor Lost Revenues Amount Receivedfrom Initial Tranche
CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche
65000000 USD
CY2020Q3 dgx Cares Act Related Expenses Or Lost Revenues Amount Received From Secondary Tranche
CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche
73000000 USD
CY2020Q4 dgx Return Of Cash Cares Act
ReturnOfCashCARESAct
138000000 USD
CY2020Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 claim
CY2020Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 claim
CY2021Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
153000000 USD
CY2020Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
138000000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2774000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2786000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8044000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6435000000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
652000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
718000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1845000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1176000000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
252000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50000000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
654000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
753000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2097000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1126000000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
153000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
483000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
269000000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
26000000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
53000000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
33000000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
527000000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
591000000 USD
us-gaap Profit Loss
ProfitLoss
1667000000 USD
us-gaap Profit Loss
ProfitLoss
890000000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
22000000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
23000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
62000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38000000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
505000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
568000000 USD
us-gaap Net Income Loss
NetIncomeLoss
1605000000 USD
us-gaap Net Income Loss
NetIncomeLoss
852000000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2774000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2786000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8044000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6435000000 USD
CY2021Q3 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
CY2020Q3 dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
dgx Percentageof Net Revenues
PercentageofNetRevenues
1
CY2021Q3 dgx Percentageof Net Accounts Receivable
PercentageofNetAccountsReceivable
1
CY2020Q4 dgx Percentageof Net Accounts Receivable
PercentageofNetAccountsReceivable
1
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2021Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
6000000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-6000000 USD
CY2020Q3 dgx Effective Tax Rate On Remeasurement Of Previously Held Equity Interest
EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest
0.118
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
70000000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-3000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
dgx Effective Tax Rate On Remeasurement Of Previously Held Equity Interest
EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest
0.118
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
70000000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-15000000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-15000000 USD

Files In Submission

Name View Source Status
0001022079-21-000144-index-headers.html Edgar Link pending
0001022079-21-000144-index.html Edgar Link pending
0001022079-21-000144.txt Edgar Link pending
0001022079-21-000144-xbrl.zip Edgar Link pending
dgx-20210930.htm Edgar Link pending
dgx-20210930.xsd Edgar Link pending
dgx-20210930_cal.xml Edgar Link unprocessable
dgx-20210930_def.xml Edgar Link unprocessable
dgx-20210930_htm.xml Edgar Link completed
dgx-20210930_lab.xml Edgar Link unprocessable
dgx-20210930_pre.xml Edgar Link unprocessable
dgx09302021ex101.htm Edgar Link pending
dgx09302021ex102.htm Edgar Link pending
dgx09302021ex22.htm Edgar Link pending
dgx09302021ex311.htm Edgar Link pending
dgx09302021ex312.htm Edgar Link pending
dgx09302021ex321.htm Edgar Link pending
dgx09302021ex322.htm Edgar Link pending
dgx09302021ex991.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending